The Trump administration has expanded its national security review to cover imports of robotics, industrial machinery, and medical devices, raising the possibility of new tariffs that could increase costs for manufacturers, hospitals, and consumers.
On September 2, the Department of Commerce launched investigations under Section 232 of the Trade Expansion Act to assess whether these imports threaten U.S. national security. The probes now include personal protective equipment such as surgical masks, N95 respirators, gloves, syringes, needles, and prescription medicines, as well as medical devices like wheelchairs, hospital beds, pacemakers, insulin pumps, and heart valves.
These investigations aim to justify tariffs that promote domestic production and reduce reliance on foreign suppliers. The Commerce Department is seeking input from companies on domestic manufacturing capabilities, foreign subsidies, and what it calls “predatory trade practices.”
Previous tariffs under Section 232 have targeted automobiles, parts, copper, steel, and aluminium. Ongoing probes into pharmaceuticals and semiconductors reflect Washington’s concern over dependence on overseas supply chains.
Data from the U.S. International Trade Commission shows heavy reliance on Mexico and China for machinery imports, which accounted for over a third of total U.S. machinery imports in 2023. The automotive sector could be particularly impacted, with most industrial robots used last year being imported.
Experts warn new levies on medical devices and protective gear risk raising healthcare costs and limiting patient access. Scott Whitaker, CEO of AdvaMed, said, “MedTech supply chain leaders are already reporting supply chain concerns, and we cannot afford to drive up the cost of health care for patients, or on the health care system.”
He added, “The reality is, any increased costs will be largely borne by taxpayer-funded health programmes like Medicare, Medicaid and the [Veterans Health Administration].”
Rick Pollack, CEO of the American Hospital Association, also noted the threat of “disruptions in the availability of these critical devices” impacting patient care.
This move shows the ongoing challenge of safeguarding national security while avoiding cost spikes in vital sectors like healthcare and manufacturing. It coincides with legislative efforts such as the Inflation Reduction Act and CHIPS and Science Act, designed to bolster domestic production and reduce foreign dependence.
Analysts caution these tariff probes could affect American industrial competitiveness, supply chains, and relations with major trade partners like China and Mexico. Companies in affected sectors will need to track developments closely.